Feifei Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Feifei Sun has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Changhui Ge
Department of Experimental Hematology and Biochemistry, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing 100850, China
1 shared publication Changyan Li
State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of lifeomics, Beijing, China
1 shared publication- Cheng Cheng
State Key Laboratory of Water Pollution Control and Green Resource Recycling, School of Environment, Nanjing University, Nanjing 210023, PR China; School of Ecology and Applied Meteorology, Nanjing University of Information Science & Technology, Nanjing 210044, Jiangsu Province, PR China
1 shared publication - Cheng Sun
Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, NMPA Key Laboratory of Research and Evaluation of Tissue Engineering Technology Products, School of Medicine, Nantong University, Nantong, China
1 shared publication - Dong Liu
School of Life Sciences, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong 226019, China
1 shared publication - Fuping Qian
Institute of Special Environmental Medicine, Nantong University, Nantong, China
1 shared publication
Latest Publications
- Open Access
- 10 August 2020
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 16 (8) , e1008953
THOC1 deficiency leads to late-onset nonsyndromic hearing loss through p53-mediated hair cell apoptosis
Apoptosis of cochlear hair cells is a key step towards age-related hearing loss. Although numerous genes have been implicated in the genetic causes of late-onset, progressive hearing loss, few show direct links to the proapoptotic process. By genome-wide linkage analysis and whole exome sequencing, we identified a heterozygous p.L183V variant in THOC1 as the probable cause of the late-onset, progressive, non-syndromic hearing loss in a large family with autosomal dominant inheritance. Thoc1, a member of the conserved multisubunit THO/TREX ribonucleoprotein complex, is highly expressed in mouse and zebrafish hair cells. The thoc1 knockout (thoc1 mutant) zebrafish generated by gRNA-Cas9 system lacks the C-startle response, indicative of the hearing dysfunction. Both Thoc1 mutant and knockdown zebrafish have greatly reduced hair cell numbers, while the latter can be rescued by embryonic microinjection of human wild-type THOC1 mRNA but to significantly lesser degree by the c.547C>G mutant mRNA. The Thoc1 deficiency resulted in marked apoptosis in zebrafish hair cells. Consistently, transcriptome sequencing of the mutants showed significantly increased gene expression in the p53-associated signaling pathway. Depletion of p53 or applying the p53 inhibitor Pifithrin-α significantly rescued the hair cell loss in the Thoc1 knockdown zebrafish. Our results suggested that THOC1 deficiency lead to late-onset, progressive hearing loss through p53-mediated hair cell apoptosis. This is to our knowledge the first human disease associated with THOC1 mutations and may shed light on the molecular mechanism underlying the age-related hearing loss. We identified a variant in THOC1 as the probable cause of the hearing loss in a large family with autosomal dominant inheritance. In addition, we showed THOC1 was expressed in mouse and zebrafish hair cells. Furthermore, we revealed that thoc1 deficiency caused the reduction of hair cell numbers in zebrafish and the hypomorphic Thoc1 induced hair cell apoptosis. These defects could be attenuated by the inhibition of p53.
- 10 August 2020
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 16 (8) , e1008953
Open AccessTHOC1 deficiency leads to late-onset nonsyndromic hearing loss through p53-mediated hair cell apoptosis
Apoptosis of cochlear hair cells is a key step towards age-related hearing loss. Although numerous genes have been implicated in the genetic causes of late-onset, progressive hearing loss, few show direct links to the proapoptotic process. By genome-wide linkage analysis and whole exome sequencing, we identified a heterozygous p.L183V variant in THOC1 as the probable cause of the late-onset, progressive, non-syndromic hearing loss in a large family with autosomal dominant inheritance. Thoc1, a member of the conserved multisubunit THO/TREX ribonucleoprotein complex, is highly expressed in mouse and zebrafish hair cells. The thoc1 knockout (thoc1 mutant) zebrafish generated by gRNA-Cas9 system lacks the C-startle response, indicative of the hearing dysfunction. Both Thoc1 mutant and knockdown zebrafish have greatly reduced hair cell numbers, while the latter can be rescued by embryonic microinjection of human wild-type THOC1 mRNA but to significantly lesser degree by the c.547C>G mutant mRNA. The Thoc1 deficiency resulted in marked apoptosis in zebrafish hair cells. Consistently, transcriptome sequencing of the mutants showed significantly increased gene expression in the p53-associated signaling pathway. Depletion of p53 or applying the p53 inhibitor Pifithrin-α significantly rescued the hair cell loss in the Thoc1 knockdown zebrafish. Our results suggested that THOC1 deficiency lead to late-onset, progressive hearing loss through p53-mediated hair cell apoptosis. This is to our knowledge the first human disease associated with THOC1 mutations and may shed light on the molecular mechanism underlying the age-related hearing loss. We identified a variant in THOC1 as the probable cause of the hearing loss in a large family with autosomal dominant inheritance. In addition, we showed THOC1 was expressed in mouse and zebrafish hair cells. Furthermore, we revealed that thoc1 deficiency caused the reduction of hair cell numbers in zebrafish and the hypomorphic Thoc1 induced hair cell apoptosis. These defects could be attenuated by the inhibition of p53.
- 30 July 2018
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 100 (1) , 281-291
CBLB502, a Toll-like receptor 5 agonist, offers protection against radiation-induced male reproductive system damage in mice†
CBLB502, a Toll-like receptor (TLR)5 agonist derived from Salmonella flagellin, was shown to protect mammalian hematopoietic and gastrointestinal systems from acute irradiation syndrome and to stimulate regeneration. To explore whether CBLB502 can improve testicular injuries caused by irradiation, mice were intraperitoneally injected with 0.2 mg/kg CBLB502 or vehicle control 30 min prior to applying 5.0 Gy ionizing radiation (IR). We observed these mice for the following 120 days and determined that CBLB502 pretreatment alleviated IR-induced oxidative stress, alleviated the distorted architecture of seminiferous tubules, reversed the decline of sperm quantity and quality, and helped recover male mouse fertility. Additionally, CBLB502 efficiently reduced DNA damage and chromosomal aberrations in IR-treated mice and their offspring. Due to the suppression of p53-dependent apoptosis, in IR-treated mice, CBLB502 was shown to significantly activate the nuclear factor kappa B (NFκB) pathway and reduce the apoptotic rate in association with an increase in anti-apoptotic B-cell lymphoma (BCL)2 levels and a decrease in the levels of DNA repair protein and proliferating cell nuclear antigen (PCNA). Moreover, an IR-induced reduction in serum testosterone and superoxide dismutase (SOD) levels and an increase in malondialdehyde (MDA) levels were considerably reversed in CBLB502-pretreated mice. No significant reverse effects were found in Tlr5 knockout mice, suggesting that protection of the testis against IR by CBLB502 is primarily dependent on the TLR5 signaling pathway. Our results may help further investigations into potential CBLB502 applications for the protection of the male reproductive system during radiotherapy.
- 30 July 2018
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 100 (1) , 281-291
CBLB502, a Toll-like receptor 5 agonist, offers protection against radiation-induced male reproductive system damage in mice†
CBLB502, a Toll-like receptor (TLR)5 agonist derived from Salmonella flagellin, was shown to protect mammalian hematopoietic and gastrointestinal systems from acute irradiation syndrome and to stimulate regeneration. To explore whether CBLB502 can improve testicular injuries caused by irradiation, mice were intraperitoneally injected with 0.2 mg/kg CBLB502 or vehicle control 30 min prior to applying 5.0 Gy ionizing radiation (IR). We observed these mice for the following 120 days and determined that CBLB502 pretreatment alleviated IR-induced oxidative stress, alleviated the distorted architecture of seminiferous tubules, reversed the decline of sperm quantity and quality, and helped recover male mouse fertility. Additionally, CBLB502 efficiently reduced DNA damage and chromosomal aberrations in IR-treated mice and their offspring. Due to the suppression of p53-dependent apoptosis, in IR-treated mice, CBLB502 was shown to significantly activate the nuclear factor kappa B (NFκB) pathway and reduce the apoptotic rate in association with an increase in anti-apoptotic B-cell lymphoma (BCL)2 levels and a decrease in the levels of DNA repair protein and proliferating cell nuclear antigen (PCNA). Moreover, an IR-induced reduction in serum testosterone and superoxide dismutase (SOD) levels and an increase in malondialdehyde (MDA) levels were considerably reversed in CBLB502-pretreated mice. No significant reverse effects were found in Tlr5 knockout mice, suggesting that protection of the testis against IR by CBLB502 is primarily dependent on the TLR5 signaling pathway. Our results may help further investigations into potential CBLB502 applications for the protection of the male reproductive system during radiotherapy.